Chairman
Vireo Growth Inc. (VREOF)Board Member
Chicago Atlantic BDC, Inc. (LIEN)Board Member
Vireo Growth Inc. (VREOF)Board Member
Chicago Atlantic Real Estate Finance, Inc. (REFI)Equibles does not estimate personal net worth.
Get an email with a short summary when Chicago Atlantic Real Estate Finance, Inc. publishes a filing, an earnings call transcript or a press release.
Get REFI alertsJohn Mazarakis is recorded as Board Member at Chicago Atlantic Real Estate Finance, Inc. (REFI) since January 1, 2021, Chairman at Chicago Atlantic Real Estate Finance, Inc. (REFI), Chairman at Vireo Growth Inc. (VREOF) since December 17, 2024, Board Member at Vireo Growth Inc. (VREOF) since January 1, 2024, CEO at Vireo Growth Inc. (VREOF) and Board Member at Chicago Atlantic BDC, Inc. (LIEN) since October 7, 2024. The newest filing on record that lists John Mazarakis as Board Member at Chicago Atlantic Real Estate Finance, Inc. (REFI) is dated April 23, 2026. The newest filing on record that lists John Mazarakis as CEO and Board Member at Vireo Growth Inc. (VREOF) is dated April 16, 2026. Chicago Atlantic BDC, Inc. reported in an 8-K filed June 24, 2025 that John Mazarakis resigned as interested Director, effective June 20, 2025. Vireo Growth Inc. reported in an 8-K filed December 23, 2024 that John Mazarakis was appointed Co-Executive Chairman of Parent. Vireo Growth Inc. reported in an 8-K filed December 23, 2024 that John Mazarakis was appointed Chief Executive Officer and Co-Executive Chairman of Parent. Equibles holds 7 filed executive changes naming John Mazarakis; each is listed under recent activity with its source filing. The proxy statement of Vireo Growth Inc. reports total compensation of $20,031,587 for John Mazarakis in fiscal 2025, including a base salary of $1. Disclosed compensation is on record for 3 fiscal years. John Mazarakis has spoken on 14 earnings calls across 2 companies, most recently for Vireo Growth Inc. on August 11, 2026. Those appearances were for Chicago Atlantic Real Estate Finance, Inc. (REFI) and Vireo Growth Inc. (VREOF). Chicago Atlantic Real Estate Finance, Inc. is classified in the REIT - Mortgage industry within the Real Estate sector. Vireo Growth Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Chicago Atlantic Real Estate Finance, Inc. includes Phillip Silverman (CFO), David Kite (COO), Anthony Cappell (Board Member) and 5 others.
“On June 19, 2025, Mr. John Mazarakis notified the Board of Directors (the “Board”) of Chicago Atlantic BDC, Inc. (the “Company”) of his resignation, effective as of June 20, 2025, from his position as an interested Director on the Company's Board.”
“John Mazarakis shall have been appointed by the board of directors of Parent as, and shall be serving as of Closing as, Chief Executive Officer and Co-Executive Chairman of Parent.”
“The second quarter was another important step forward for Virial. We delivered strong financial performance while continuing to execute against what we believe is one of the most differentiated growth strategies in the cannabis industry.”
“Over the past several months, we've closed Swag's East Hawthorne and the Pharmacan MSA, adding over $100 million of quarterly revenue to our top line. The results are transformative as we're now the fourth largest cannabis company by revenue on a Proforma basis.”
“We're pleased to report another strong quarter for Vireo highlighted by double-digit organic growth and continued integration progress across our extended platform.”
“Subsequent to quarter end, we announced the acquisition of 86% of the outstanding senior secured convertible nodes of U.S. multi-state cannabis operator SWAS. We've entered into a restructuring support agreement with SWAS, which once completed will result in Vireo owning the majority of SWAS's total assets.”
“Vireo's legacy markets are performing in line with our expectations and reflected a continuation of the trends that we discussed during the first quarter.”
2024-12-17–present
2024-10-07–present
2024-01-01–present
Last confirmed April 16, 2026
2021-01-01–present
Last confirmed April 23, 2026
Start not stated–present
Last confirmed April 16, 2026
Start not stated–2025-06-20
REIT - Mortgage · Real Estate
Chairman, Board Member
2021-01-01–present
VREOF
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Chairman, Board Member
2024-01-01–present
Asset Management · Financial Services
Board Member
2024-10-07–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vireo Growth Inc. (VREOF) | Chief Executive Officer and Co-Executive Chairman | $1 | $20,031,587 |
| 2024 | Vireo Growth Inc. (VREOF) | Chief Executive Officer and Co-Executive Chairman | — | $800,000 |
| 2023 | Vireo Growth Inc. (VREOF) | Chief Executive Officer and Co-Executive Chairman | — | — |
